Literature DB >> 20657501

Microwave-assisted one-pot synthesis of pyrazolone derivatives under solvent-free conditions.

Ruoqun Ma1, Jin Zhu, Jie Liu, Lili Chen, Xu Shen, Hualiang Jiang, Jian Li.   

Abstract

An efficient one-pot method to generate structurally diverse and medicinally interesting pyrazolone derivatives in good to excellent yields of 51-98% under microwave irradiation and solvent-free conditions has been developed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20657501      PMCID: PMC6263256          DOI: 10.3390/molecules15053593

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Pyrazolone derivatives are an important class of heterocyclic compounds that occur in many drugs and synthetic products [1]. These compounds exhibit remarkable antitubercular [2,3], antifungal [4,5], antibacterial [6], anti-inflammatory [7], and antitumor activities [8]. In our effort to identify new farnesoid X receptor (FXR) ligands [9], we recently found by virtual screening that a 4-arylidene-pyrazolone derivative 1a (Figure 1) was a FXR antagonist (unpublished data). Consequently, to explore the structure activity relationships (SAR) for this family of compounds, a facile and practical approach for synthesizing 4-arylidenepyrazolone-containing derivatives 1 (Figure 1) became desirable.
Figure 1

The structures of 4-arylidenepyrazolone derivatives 1 and FXR antagonist 1a.

The structures of 4-arylidenepyrazolone derivatives 1 and FXR antagonist 1a. Generally, 4-arylidenepyrazolone derivatives 1 are synthesized using as starting materials substituted aldehydes 5 [10,11,12] (or their their acetal [13,14] or imine [15,16] precursors) and 2-pyrazolin-5-ones 4, the latter generally being obtained by the Knorr condensation [17,18] of β-ketoesters 2 with substituted hydrazines 3 (Scheme 1). It is obvious that all described methods involve multiple step reactions and most of them produce equimolar amounts of unwanted by-products. In this respect, the development of a one-pot reaction using readily available chemicals would be of considerable significance due to its synthetic efficiency and atom economy.
Scheme 1

The synthetic routes to 4-arylidenepyrazolone derivatives 1 by classical two step or the proposed one-pot method.

The synthetic routes to 4-arylidenepyrazolone derivatives 1 by classical two step or the proposed one-pot method. Microwave-assisted organic reactions have been applied to a wide range of reaction types [19,20,21,22,23,24,25], especially cycloaddition reactions. Microwaves accelerate a variety of synthetic transformations providing time- and energy-saving protocols [19,20,21,22,23,24,25]. Recently, Botta et al. [26]. reported a microwave-assisted three-component Knoevenagel/hetero Diels–Alder reaction, which suggested that 2-pyrazolin-5-ones 4 might react well with aldehydes 5 under microwave irradiation conditions. Inspired by this reaction, we envisioned that a new three-component (compounds 2, 3, and 5) one-pot reaction might take place using a microwave-assisted approach and would directly create the target 4-arylidene-pyrazolone scaffolds 1 (Scheme 1).

2. Results and Discussion

2.1. Optimization of the reaction conditions

Initially we selected ethyl acetoacetate (2a), 3-nitrophenylhydrazine (3b) and 3-methoxy-4-ethoxy-benzaldehyde (5a) as the model substrates for the optimization of the reaction conditions, which included microwave oven power, time of irradiation, solid supports and reactant ratios. The results are summarized in Table 1-Table 2. The preliminary investigations revealed that the one-pot reaction occurred, as designed. Nevertheless, the reaction efficiency was highly microwave oven power dependent (entries 1-3, Table 1), with a good yield being achieved at 420 W. We then compared the synthesis of 1b with irradiation times of 5 min, 10 min, and 15 min at 420 W, and the corresponding yields were 54%, 71%, and 62%, respectively (entries 2 and 4,5, Table 1).
Table 1

Optimization of the power of microwave oven and time of irradiation.

EntryPower (W)Time (min)Yield (%)b
1280520
2420567
3560554
44201071
54201562

the reaction was carried out with 2a, 3b and 5a in equimolar ratio (0.3 mmol); for the detailed reaction conditions see the Experimental section; Isolated yields.

Table 2

Optimization of the reactant’s equivalence ratio and solid support.

EntrySolid supportReagent RatioYield (%)b
2a3b5a
1-11.2160
2-1.21178
3-111.263
4-1.51183
5-21173
6-2.51179
7-31181
8SiO21.51181
9Al2O31.51180

The reaction was carried out under microwave radiation 420 W for 10 min; for detailed reaction conditions see the Experimental section; Isolated yields.

Optimization of the power of microwave oven and time of irradiation. the reaction was carried out with 2a, 3b and 5a in equimolar ratio (0.3 mmol); for the detailed reaction conditions see the Experimental section; Isolated yields. Optimization of the reactant’s equivalence ratio and solid support. The reaction was carried out under microwave radiation 420 W for 10 min; for detailed reaction conditions see the Experimental section; Isolated yields. Encouraged by the promising results, we further optimized the reactant ratio (entries 1–7, Table 2) and solid support (entries 8,9, Table 2). The optimum results were obtained when the reactants were mixed is a ratio of 2a/3b/5a = 1.5/1/1 without solid support and irradiated at 420 W for 10 min (entry 4, Table 2). Solid supports such as aluminium oxides and silica gel have been widely used in microwave-assisted organic synthesis to enhance substrates absorption of microwave energy. However, solid supports appeared to offer no advantages in our one-pot reaction (entries 4, and 8,9, Table 2).

2.2. Scope of microwave-assisted one-pot synthesis of 4-arylidenepyrazolone derivatives

Having established the optimal reaction conditions, we subjected a series of β-ketoesters, hydrazines, and aldehydes to them to explore the generality and scope of the one-pot process. As shown in Table 3, we were pleased to find that this method was applicable to a broad range substrate of substituted β-ketoester (2a-b), hydrazine (3a-j), and aldehyde (5a-h) substrates.
Table 3

Scope of microwave-assisted one-pot synthesis of 4-arylidenepyrazolone derivatives.

Compd.R1R2ArYield (%)b
1a Me, 2a3-CO2H, 3a3-MeO-4-EtO-Ph, 5a98
1b Me, 2a3-NO2, 3b3-MeO-4-EtO-Ph, 5a83
1c Me, 2a4-NO2, 3c3-MeO-4-EtO-Ph, 5a78
1d Me, 2a4-CF3, 3d 3-MeO-4-EtO-Ph, 5a53
1e Me, 2a3-CF3, 3e3-MeO-4-EtO-Ph, 5a67c
1f Me, 2a3,5-di-CF3, 3f3-MeO-4-EtO-Ph, 5a54c
1g Me, 2a2-F, 3g3-MeO-4-EtO-Ph, 5a51
1h Me, 2a3,4-di-Cl, 3h3-MeO-4-EtO-Ph, 5a86
1i Me, 2a3,5-di-Cl, 3i3-MeO-4-EtO-Ph, 5a73c
1j Me, 2a3-CO2H, 3a3-MeO-4-OH-Ph, 5b68
1k Me, 2a3-CO2H, 3a3,4-di-OH-Ph, 5c73
1l Me, 2a3-NO2, 3b5-Me-thiophen-2-yl, 5d53
1m Me, 2aH, 3j3-MeO-4-EtO-Ph, 5a63
1n Me, 2aH, 3j4-Br-Ph, 5e53c
1o Ph, 2b3-NO2, 3b3-MeO-4-OH-Ph, 5c61
1p Me, 2a3-CO2H, 3a3-MeO-4-PhCH2O-Ph, 5f84
1q Me, 2a3-CO2H, 3a3-MeO-4-Me(CH2)4O-Ph, 5g83
1r Me, 2a3-CO2H, 3a3-MeO-4-Me2CHO-Ph, 5h76

Unless stated otherwise, the reaction was carried out with 2 (0.45 mmol), 3 (0.3 mmol) and 5 (0.3 mmol) under microwave radiation 420 W for 10 min; for the detailed reaction conditions see the Experimental section; Isolated yields; These reactions were carried out with 2 (0.36 mmol), 3 (0.3 mmol) and 5 (0.3 mmol).

Scope of microwave-assisted one-pot synthesis of 4-arylidenepyrazolone derivatives. Unless stated otherwise, the reaction was carried out with 2 (0.45 mmol), 3 (0.3 mmol) and 5 (0.3 mmol) under microwave radiation 420 W for 10 min; for the detailed reaction conditions see the Experimental section; Isolated yields; These reactions were carried out with 2 (0.36 mmol), 3 (0.3 mmol) and 5 (0.3 mmol). The target products 1a-r were prepared in good to excellent yields (51–98%). A variety of substituents on the aryl ring including halogens, -CO2H, -NO2, -CF3, alkoxy, etc. were well tolerated. These outcomes imply that electronic features have a marginal effect on the process. Examination of the results also revealed that the steric effects also play a minimal role in governing the reaction efficiency, as all para- (such as compound 1c), meta- (such as compound 1e), and ortho- (such as compound 1g) substituted substrates were smoothly transformed into the desired products. Heterocycles (compound 1l) could efficiently participate in the one-pot reaction as well. Finally, it is noteworthy that the process features simple operation and purification, and all target products could be directly obtained by simple suction filtration and washing with ethyl acetate. With regard to the stereochemistry of the 4-arylidenepyrazolone products 1a-r, they were all exclusively assigned the Z-configuration based on NOE spectroscopy of compound 1b. NOE was observed between H-13 (δ 7.37) and H-12 (δ 2.38), suggesting a Z configuration at Δ[ (Figure 2).
Figure 2

NOE correlation (double-headed arrows) established the stereochemistry of the double bond in 1b.

NOE correlation (double-headed arrows) established the stereochemistry of the double bond in 1b.

3. Experimental

3.1. General

The reagents were purchased from Shanghai Chemical Reagent Company, Lancaster, and Acros, and used without further purification. Yields were not optimized. Nuclear magnetic resonance (NMR) spectra were recorded on a Brucker AMX-400 NMR instrument (1H at 400 MHz and 13C at 100 MHz, respectively). Chemical shifts are reported in parts per million (ppm, δ) downfield from tetramethylsilane (TMS) used as internal standard. Proton coupling patterns were described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br). Low- and high-resolution mass spectra (LRMS and HRMS) were obtained by electron ionization (EI) on a Finnigan MAT-95 instrument. Microwave experiments were carried out in a domestic microwave oven (Midea MM721AAU-PW).

3.2. General Procedure for the Preparation of : Preparation of

(Z)-4-(4-Ethoxy-3-methoxybenzylidene)-3-methyl-1-(3-nitrophenyl)-pyrazolone (1b). A one-neck 50-mL flask containing ethyl acetoacetate (2a, 0.45 mmol), 3-nitrophenylhydrazine (3b, 0.3 mmol) and 3-methoxy-4-ethoxy-benzaldehyde (5a, 0.3 mmol) was placed in a domestic microwave oven and irradiated at a power of 420 W for 10 min. The solid obtained after cooling was triturated with ethyl acetate and collected by suction filtration, to afford product 1b (95 mg, yield 83%) as an orange solid. m.p. 212–213 ºC. 1H-NMR (CDCl3): δ 1.55 (t, 3H), 2.38 (s, 3H), 4.07 (s, 3H), 4.27 (q, 2H), 6.98 (d, 1H), 7.37 (s, 1H), 7.59 (t, 1H), 7.75 (d, 1H), 8.03 (d, 1H), 8.47 (d, 1H), 8.93 (d, 2H); 13C-NMR (CDCl3): δ 162.7, 153.6, 152.1, 149.0, 148.6, 148.3, 139.6, 130.9, 129.6, 126.5, 124.0, 123.9, 118.8, 115.8, 113.5, 111.4, 64.7, 56.4, 14.6, 13.5; EI-MS m/z 381 (M+, 100%); HRMS (EI) m/z calcd. C20H19N3O5 (M+) 381.1325, found 381.1321. (Z)-3-(4-(4-Ethoxy-3-methoxybenzylidene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid (1a). Solid. m.p. 276–278 ºC. 1H-NMR (DMSO): δ 1.38 (t, 3H), 2.34 (s, 3H), 3.88 (s, 3H), 4.17 (q, 2H), 7.16 (d, 1H), 7.56 (t, 1H), 7.77 (s, 2H), 8.12 (d, 1H), 8.21 (d, 1H), 8.51 (s, 1H), 8.75 (s, 1H), 13.05 (s, 1H); EI-MS m/z 380 (M+, 100%); HRMS (EI) m/z calcd. C21H20N2O5 (M+) 380.1372, found 380.1371. (Z)-4-(4-Ethoxy-3-methoxybenzylidene)-3-methyl-1-(4-nitrophenyl)-1H-pyrazol-5(4H)-one (1c). Solid. m.p. 213–215 ºC. 1H-NMR (CDCl3): δ 1.55 (t, 3H), 2.38 (s, 3H), 4.06 (s, 3H), 4.25 (q, 2H), 6.97 (d, 1H), 7.37 (s, 1H), 7.73 (d, 1H), 8.29 (s, 4H), 8.90 (s, 1H); EI-MS m/z 381 (M+, 100%); HRMS (EI) m/z calcd. C20H19N3O5 (M+) 381.1325, found 381.1323. (Z)-4-(4-Ethoxy-3-methoxybenzylidene)-3-methyl-1-(4-(trifluoromethyl)phenyl)-1H-pyrazol-5(4H)-one (1d).Solid. m.p. 144–147 ºC. 1H-NMR (CDCl3): δ 1.54 (t, 3H), 2.37 (s, 3H), 4.05 (s, 3H), 4.25 (q, 2H), 6.96 (d, 1H), 7.35 (s, 1H), 7.66 (d, 2H), 7.72 (d, 1H), 8.18 (d, 2H), 8.93 (s, 1H); EI-MS m/z 404 (M+, 100%); HRMS (EI) m/z calcd. C21H19F3N2O3 (M+) 404.1348, found 404.1349. (Z)-4-(4-Ethoxy-3-methoxybenzylidene)-3-methyl-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-5(4H)-one (1e). Solid. m.p. 147–151 ºC. 1H-NMR (CDCl3): δ 1.54 (t, 3H), 2.37 (s, 3H), 4.06 (s, 3H), 4.24 (q, 2H), 6.97 (d, 1H), 7.35 (s, 1H), 7.42 (d, 1H), 7.53 (t, 1H), 7.75 (d, 1H), 8.28 (d, 1H), 8.31 (s, 1H), 8.91 (s, 1H); EI-MS m/z 404 (M+, 100%); HRMS (EI) m/z calcd. C21H19F3N2O3 (M+) 404.1348, found 404.1349. (Z)-1-(3,5-bis(Trifluoromethyl)phenyl)-4-(4-ethoxy-3-methoxybenzylidene)-3-methyl-1H-pyrazol-5(4H)-one (1f).Solid. m.p. 198–200 ºC. 1H-NMR (CDCl3): δ 1.54 (t, 3H), 2.38 (s, 3H), 4.07 (s, 3H), 4.25 (q, 2H), 6.98 (d, 1H), 7.37 (s, 1H), 7.65 (s, 1H), 7.77 (d, 1H), 8.61 (s, 2H), 8.84 (s, 1H); EI-MS m/z 472 (M+, 100%); HRMS (EI) m/z calcd. C22H18F6N2O3 (M+) 472.1222, found 472.1223. (Z)-4-(4-Ethoxy-3-methoxybenzylidene)-1-(2-fluorophenyl)-3-methyl-1H-pyrazol-5(4H)-one (1g).Solid. m.p. 153–155 ºC. 1H-NMR (CDCl3): δ 1.52 (t, 3H), 2.34 (s, 3H), 4.00 (s, 3H), 4.22 (q, 2H), 6.93 (d, 1H), 7.22 (q, 2H), 7.32 (t, 1H), 7.36 (s, 1H), 7.52 (t, 1H), 7.67 (d, 1H); EI-MS m/z 354 (M+, 100%); HRMS (EI) m/z calcd. C20H19FN2O3 (M+) 354.1380, found 354.1377. (Z)-1-(3,4-Dichlorophenyl)-4-(4-ethoxy-3-methoxybenzylidene)-3-methyl-1H-pyrazol-5(4H)-one (1h). Solid. m.p. 164–166 ºC. 1H-NMR (CDCl3): δ 1.53 (t, 3H), 2.34 (s, 3H), 4.05 (s, 3H), 4.23 (q, 2H), 6.95 (d, 1H), 7.32 (s, 1H), 7.44 (s, 1H), 7.71 (d, 1H), 7.94 (d, 1H), 8.21 (s, 1H), 8.90 (s, 1H); EI-MS m/z 404 (M+, 100%); HRMS (EI) m/z calcd. C22H18F6N2O3 (M+) 404.0694, found 404.0695. (Z)-1-(3,5-Dichlorophenyl)-4-(4-ethoxy-3-methoxybenzylidene)-3-methyl-1H-pyrazol-5(4H)-one (1i).Solid. m.p. 182–185 ºC. 1H-NMR (CDCl3): δ 1.54 (t, 3H), 2.35 (s, 3H), 4.06 (s, 3H), 4.23 (q, 2H), 6.96 (d, 1H), 7.15 (s, 1H), 7.33 (s, 1H), 7.72 (d, 1H), 8.04 (s, 2H), 8.89 (s, 1H); EI-MS m/z 404 (M+, 100%); HRMS (EI) m/z calcd. C22H18F6N2O3 (M+) 404.0694, found 404.0697. (Z)-3-(4-(4-Hydroxy-3-methoxybenzylidene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid (1j).Solid. m.p. 255–257 ºC. 1H-NMR (DMSO): δ 2.33 (s, 3H), 3.90 (s, 3H), 6.96 (d, 1H), 7.56 (t, 1H), 7.70 (s, 1H), 7.75 (d, 1H), 8.04 (d, 1H), 8.21 (d, 1H), 8.53 (s, 1H), 8.76 (s, 1H); EI-MS m/z 352 (M+, 100%); HRMS (EI) m/z calcd. C19H16N2O5 (M+) 352.1059, found 352.1057. (Z)-3-(4-(3,4-Dihydroxybenzylidene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl) benzoic acid (1k).Solid. m.p. 278–280 ºC. 1H-NMR (DMSO): δ 2.34 (s, 3H), 6.93 (d, 1H), 7.57 (t, 1H), 7.65 (s, 1H), 7.76 (d, 1H), 7.92 (d, 1H), 8.18 (d, 1H), 8.52 (s, 1H), 8.63 (s, 1H), 10.45(s,1H); EI-MS m/z 338 (M+, 100%); HRMS (EI) m/z calcd. C19H16N2O5 (M+) 338.0903, found 338.0782. (Z)-3-Methyl-4-((5-methylthiophen-2-yl)methylene)-1-(3-nitrophenyl)-1H-pyrazol-5(4H)-one (1l). Solid. m.p. 199–201 ºC. 1H-NMR (CDCl3): δ 2.39 (s, 1H), 2.67 (s, 3H), 7.00 (s, 1H), 7.58 (t, 2H), 7.85 (s, 1H), 8.02 (d, 1H), 8.53 (d, 1H), 8.92 (s, 1H); EI-MS m/z 327 (M+, 100%); HRMS (EI) m/z calcd. C16H13N3O3S (M+) 327.0678, found 327.0675. (Z)-4-(4-Ethoxy-3-methoxybenzylidene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (1m).Solid. m.p. 134–139 ºC. 1H-NMR (CDCl3): δ 1.54 (t,3H), 2.36 (s, 3H), 4.05 (s, 3H), 4.23 (q, 2H), 6.95 (d, 1H), 7.19 (t, 1H), 7.32 (s, 1H), 7.42 (t, 2H), 7.72 (d, 1H), 7.97 (d, 2H), 8.98 (s, 1H); EI-MS m/z 336 (M+, 100%); HRMS (EI) m/z calcd. C20H20N2O3 (M+) 336.1474, found 336.1475. (Z)-4-(4-Bromobenzylidene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (1n). Solid. m.p. 117–120 ºC. 1H-NMR (CDCl3): δ 2.36 (s, 3H), 7.21 (t, 1H), 7.32 (s, 1H), 7.43 (t, 2H), 7.65 (d, 2H), 7.95 (d, 2H), 8.39 (d, 2H); EI-MS m/z 340 (M+, 100%); HRMS (EI) m/z calcd. C17H13BrN2O (M+) 340.0211, found 340.0212. (Z)-4-(4-Hydroxy-3-methoxybenzylidene)-1-(3-nitrophenyl)-3-phenyl-1H-pyrazol-5(4H)-one (1o). Solid. m.p. 199–202 ºC. 1H-NMR (CDCl3): δ 4.14 (s, 3H), 6.38 (s, 1H), 7.03 (d, 1H), 7.53 (d, 1H), 7.56 (m, 4H), 7.69 (d, 1H), 7.71 (d, 1H), 8.07 (d, 1H), 8.54 (d, 1H), 9.06 (s, 1H), 9.15 (s, 1H); EI-MS m/z 415 (M+, 100%); HRMS (EI) m/z calcd. C23H17N3O5 (M+) 415.1168, found 415.1159. (Z)-3-(4-(4-(Benzyloxy)-3-methoxybenzylidene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid(1p).Solid. m.p. 249–252 ºC. 1H-NMR (DMSO): δ 2.35 (s, 3H), 3.89 (s, 3H), 5.26 (s,2H), 7.28–7.50 (m, 7H), 7.57 (t, 1H), 7.77 (d, 2H), 8.14 (d, 1H), 8.22 (d, 1H), 8.52 (s, 1H), 8.77 (s, 1H); EI-MS m/z 442 (M+, 100%); HRMS (EI) m/z calcd C26H22N2O5 (M+) 442.1529, found 442.1530. (Z)-3-(4-(3-Methoxy-4-(pentyloxy)benzylidene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid (1q).Solid. m.p. 224–226 ºC. 1H-NMR (DMSO): δ 0.91 (t, 3H), 1.32–1.43 (m, 4H), 1.77 (m, 2H), 2.35 (s, 3H), 3.88 (s, 3H), 4.11 (t, 2H), 7.18 (d,1H), 7.57 (t, 1H), 7.77 (d, 2H), 8.13 (d, 1H), 8.22 (d, 1H), 8.52 (s, 1H), 8.77 (s, 1H); EI-MS m/z 422 (M+, 100%); HRMS (EI) m/z calcd. C24H26N2O5 (M+) 422.1842, found 422.1840. (Z)-3-(4-(4-Isopropoxy-3-methoxybenzylidene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid (1r).Solid. m.p. 206–208 ºC. 1H-NMR (DMSO): δ 1.33 (s, 6H), 2.36 (s, 3H), 3.87 (s, 3H), 4.83 (m, 1H), 7,21 (d, 1H), 7.57 (t,1H), 7.76 (d, 1H), 7.79 (s, 1H), 8.15 (d, 1H), 8.22 (d, 1H), 8.53 (s, 1H), 8.75 (s, 1H); EI-MS m/z 394 (M+, 100%); HRMS (EI) m/z calcd. C24H26N2O5 (M+) 394.1529, found 394.1528.

4. Conclusions

We have developed a simple, rapid, and efficient one-pot protocol for the preparation of the 4-arylidenepyrazolone derivatives by a solvent-free, microwave-assisted reaction. Furthermore, the procedure used commercially available reagents, giving the desired compounds in good to excellent yields (51–98%). The versatility of this methodology makes it suitable for library synthesis in drug discovery efforts.
  2 in total

1.  Streocontrolled construction of six vicinal stereogenic centers on spiropyrazolones via organocascade Michael/Michael/1,2-addition reactions.

Authors:  Pankaj Chauhan; Suruchi Mahajan; Charles C J Loh; Gerhard Raabe; Dieter Enders
Journal:  Org Lett       Date:  2014-05-19       Impact factor: 6.005

2.  Microwave-assisted synthesis of biologically relevant steroidal 17-exo-pyrazol-5'-ones from a norpregnene precursor by a side-chain elongation/heterocyclization sequence.

Authors:  Gergő Mótyán; László Mérai; Márton Attila Kiss; Zsuzsanna Schelz; Izabella Sinka; István Zupkó; Éva Frank
Journal:  Beilstein J Org Chem       Date:  2018-10-08       Impact factor: 2.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.